Revvity
Shripad Joshi is a seasoned executive with extensive experience in the life sciences and diagnostics sectors. Currently serving as President for India and South Asia and General Manager for the Global ESA Portfolio at Revvity since May 2023, Shripad previously held a concurrent role as General Manager of the Global ESA Portfolio at PerkinElmer (India) from December 2022 to May 2023. Shripad's tenure at PerkinElmer spans several roles, including President and Director for India & South Asia, focusing on revenue, profitability, and growth across multiple countries. With a background in managing P&L and strategic objectives for various portfolios, Shripad also held significant positions at Agilent Technologies and Merck Limited. Academic credentials include a Senior Management Program from the Indian Institute of Management, Calcutta, and a Bachelor's in Medical Electronics from Bangalore University.
This person is not in any teams
This person is not in any offices
Revvity
9 followers
At Revvity, “impossible” is inspiration, and ""can't be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries. Learn more at www.revvity.com